Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of innovative therapeutics for hematologic malignancies - cancers that affect blood and bone marrow. Founded in 1990, Geron has office locations in Foster City, California and Parsippany, New Jersey. A United Kingdom subsidiary was established in late 2021.